Epiprogoitrin potassium salt
| Product Name | Epiprogoitrin potassium salt |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-49091 |
| CAS No. | 21087-74-1 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 428.5 g/mol |
| Mol. For. | C11H19NO10S2.K |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
FucGM1Cer d18:1/16:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Lacto-N-difucohexaose | Ac3 GlcNAcproN3 | GD1aCer d18:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d18:1/20:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | iGB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GM2sph d18:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GD2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Sakuranin | Lactose PEG-NH2 | GD1aCer d20:1/8:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Glucoerucin potassium salt | Gala1, 3Galb1, 4Glc | GM3Cer d18:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GM2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | i(Galb1,4GlcNAcb1,3Galb1,4GlcNAcb1,3GalbR) | GQ3Cer d20:1/18:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD1bCer d20:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | iGloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GM2Cer d18:1/18:0-Biotin (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | Galc d18:1/18:0（GalaCeramide） | FucGM1Cer d18:1/18:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d20:1/20:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcCer d20:1/20:0 (GlcbCeramide) | FucGM1Cer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | Ac4 ManNAc | GT2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | SSEA-4 d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | Blood type tetrasaccharide A Type VI | GD1bCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d20:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Pk(Gala1,4Galb1,4GlcbR) | GT2 | Neu5Aca2,3（HSO4 -6-)Galb1,4GlcNAc | GalNAcb1, 3Gal | GD1aCer d20:1/18:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | SiaNAl | Gluconasturtiin potassium salt | Blood type trisaccharide H Type III/IV | Ac3 6-AzManNAc | GQ3Cer d20:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GQ3sph d18:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | GT2Cer d20:1/16:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1cCer d20:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d18:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Neu5Gca2, 3Galb1, 4GlcNAc | GM2sph d20:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GlcNAcb1, 3Gal | GD2Cer d18:1/8:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GloboH | D-fructofuranose | Glucobrassicine | C24:1 β-Glucosylceramide | GlcCer d20:1/18:0 (GlcbCeramide) | Lewis Y (Le Y) | GD2Cer d20:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3sph d20:1 (Neu5Aca2,3Galb1,4GlcbSphingolipids) | GT2sph d18:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Lewis A (Lea ) pentasaccharide | GM1aCer d18:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT1cCer d20:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Lacto-N-difucohexaose II | GD3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) |